{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:49:22Z","timestamp":1791823762024,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mammary Gland Biol Neoplasia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10911-026-09615-w","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:45:47Z","timestamp":1784263547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential effects of oral contraceptives on lymph node metastasis in breast cancer: role of tumor size as an effect modifier"],"prefix":"10.1007","volume":"31","author":[{"given":"Yang","family":"Saimei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Baodong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"9615_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"9615_CR2","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ijc.33588","volume":"149","author":"J Ferlay","year":"2021","unstructured":"Ferlay J, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149:778\u201389.","journal-title":"Int J Cancer"},{"key":"9615_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181\u20137.","journal-title":"Cancer"},{"key":"9615_CR4","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3","volume":"52","author":"B Fisher","year":"1983","unstructured":"Fisher B, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer. 1983;52:1551\u20137.","journal-title":"Cancer"},{"key":"9615_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, Van \u2019T, Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5:591\u2013602.","journal-title":"Nat Rev Cancer"},{"key":"9615_CR6","doi-asserted-by":"publisher","first-page":"1487820","DOI":"10.3389\/fgwh.2024.1487820","volume":"5","author":"S Jahanfar","year":"2024","unstructured":"Jahanfar S, et al. Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age-a systematic review. Front Glob Women\u2019s Health. 2024;5:1487820.","journal-title":"Front Glob Women\u2019s Health"},{"key":"9615_CR7","doi-asserted-by":"publisher","first-page":"e0213615","DOI":"10.1371\/journal.pone.0213615","volume":"14","author":"PJ Ho","year":"2019","unstructured":"Ho PJ, et al. Factors associated with false-positive mammography at first screen in an Asian population. PLoS ONE. 2019;14:e0213615.","journal-title":"PLoS ONE"},{"key":"9615_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4274\/ejbh.galenos.2021.2021-4-3","volume":"17","author":"H Zhu","year":"2021","unstructured":"Zhu H, Do\u011fan BE. American Joint Committee on Cancer\u2019s Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians. Eur J Breast Health. 2021;17:234\u20138.","journal-title":"Eur J Breast Health"},{"key":"9615_CR9","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-13-3400","volume":"74","author":"EF Beaber","year":"2014","unstructured":"Beaber EF, et al. Recent oral contraceptive use by formulation and breast cancer risk among women 20\u201349 years of age. Cancer Res. 2014;74:4078\u201389.","journal-title":"Cancer Res"},{"key":"9615_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-08-1005","volume":"18","author":"JM Dolle","year":"2009","unstructured":"Dolle JM, et al. Risk Factors for Triple-Negative Breast Cancer in Women Under Age 45. Cancer Epidemiol Biomark Prev. 2009;18:1157\u201366.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9615_CR11","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.1994.12.7.1422","volume":"12","author":"CL Loprinzi","year":"1994","unstructured":"Loprinzi CL, Ravdin PM, De Laurentiis M, Novotny P. Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol. 1994;12:1422\u20136.","journal-title":"J Clin Oncol"},{"key":"9615_CR12","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci"},{"key":"9615_CR13","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747\u201352.","journal-title":"Nature"},{"key":"9615_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13058-015-0524-0","volume":"17","author":"BT Kren","year":"2015","unstructured":"Kren BT, et al. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Breast Cancer Res. 2015;17:19.","journal-title":"Breast Cancer Res"},{"key":"9615_CR15","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1158\/1055-9965.EPI-05-0116","volume":"14","author":"A Stuedal","year":"2005","unstructured":"Stuedal A, et al. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women. Cancer Epidemiol Biomark Prev. 2005;14:2154\u20139.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9615_CR16","doi-asserted-by":"crossref","unstructured":"Slaoui M et al. Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution. PLoS ONE. 2016.","DOI":"10.1371\/journal.pone.0164841"},{"key":"9615_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1186\/s12885-023-11643-2","volume":"23","author":"D Dai","year":"2023","unstructured":"Dai D, et al. Genetic and clinical landscape of ER + \/PR- breast cancer in China. BMC Cancer. 2023;23:1189.","journal-title":"BMC Cancer"},{"key":"9615_CR18","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","volume":"24","author":"A Goldhirsch","year":"2013","unstructured":"Goldhirsch A, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206\u201323.","journal-title":"Ann Oncol"},{"key":"9615_CR19","doi-asserted-by":"crossref","unstructured":"Lin Y et al. Survival and clinicopathological significance of blood vessel invasion in operable breast cancer: a systematic review and meta-analysis. Jpn J Clin Oncol (2022).","DOI":"10.1093\/jjco\/hyac149"},{"key":"9615_CR20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2022.11.007","volume":"131","author":"J Chen","year":"2023","unstructured":"Chen J, et al. Further predictive value of lymphovascular invasion explored via supervised deep learning for lymph node metastases in breast cancer. Hum Pathol. 2023;131:26\u201337.","journal-title":"Hum Pathol"},{"key":"9615_CR21","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.nwh.2022.01.003","volume":"26","author":"K Smrekar","year":"2022","unstructured":"Smrekar K, Lodise NM. Combined Oral Contraceptive Use and Breast Cancer Risk: Select Considerations for Clinicians. Nurs Women\u2019s Health. 2022;26:242\u20139.","journal-title":"Nurs Women\u2019s Health"},{"key":"9615_CR22","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky K, et al. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021;385:2336\u201347.","journal-title":"N Engl J Med"},{"key":"9615_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13256-020-02366-0","volume":"14","author":"P Thasanabanchong","year":"2020","unstructured":"Thasanabanchong P, Vongsaisuwon M. Unexpected presentation of accessory breast cancer presenting as a subcutaneous mass at costal ridge: a case report. J Med Case Rep. 2020;14:45.","journal-title":"J Med Case Rep"},{"key":"9615_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/BF01806495","volume":"37","author":"PL Choong","year":"1996","unstructured":"Choong PL, et al. Predicting axillary lymph node metastases in breast carcinoma patients. Breast Cancer Res Treat. 1996;37:135\u201349.","journal-title":"Breast Cancer Res Treat"},{"key":"9615_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.amjsurg.2008.06.013","volume":"196","author":"CR Barkley","year":"2008","unstructured":"Barkley CR, et al. Mucinous breast carcinoma: a large contemporary series. Am J Surg. 2008;196:549\u201351.","journal-title":"Am J Surg"},{"key":"9615_CR26","doi-asserted-by":"crossref","unstructured":"Wu L, Zhou X, Yang F. Assessing the Relationship among Tumor Size, Lymph Node Status, and ER\/PR\/HER2 Expression in Patients with Breast Cancer. 2025;45.","DOI":"10.1615\/CritRevImmunol.2025055318"},{"key":"9615_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.30699\/ijp.2025.2040168.3350","volume":"20","author":"M Soltan","year":"2025","unstructured":"Soltan M, Naimi A, Hafez Forghan R, Mansourian M. Evaluation of the Role of Claudin-4 Antigen Overexpression in Triple-Negative Breast Cancer Patients: A 5-Year Survival Analysis. Iran J Pathol. 2025;20:167\u201372.","journal-title":"Iran J Pathol"},{"key":"9615_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1023\/A:1005790531122","volume":"43","author":"LJ Schouten","year":"1997","unstructured":"Schouten LJ, et al. Prognostic significance of etiological risk factors in early breast cancer. Breast Cancer Res Treat. 1997;43:217\u201323.","journal-title":"Breast Cancer Res Treat"},{"key":"9615_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/sj.bjc.6604120","volume":"98","author":"H Thorpe","year":"2008","unstructured":"Thorpe H, et al. Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: The ITS Study. Br J Cancer. 2008;98:39\u201344.","journal-title":"Br J Cancer"},{"key":"9615_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s002920050156","volume":"17","author":"I Sch\u00f6nborn","year":"1996","unstructured":"Sch\u00f6nborn I, Minguillon C, Zschiesche W, M\u00f6hner M, Ebeling K. C-erbB-2, PCNA und histomorphologische Faktoren beim Mammakarzinom nach Einnahme oraler Kontrazeptiva. Pathologe. 1996;17:202\u20137.","journal-title":"Pathologe"},{"key":"9615_CR31","first-page":"184","volume":"22","author":"O Unlu","year":"2017","unstructured":"Unlu O, et al. Risk factors and histopathological features of breast cancer among women with different menopausal status and age at diagnosis. J B U : off j Balk Union Oncol. 2017;22:184\u201391.","journal-title":"J B U : off j Balk Union Oncol"},{"key":"9615_CR32","doi-asserted-by":"publisher","first-page":"e0221776","DOI":"10.1371\/journal.pone.0221776","volume":"14","author":"D Ferreira","year":"2019","unstructured":"Ferreira D, et al. Gene expression association study in feline mammary carcinomas. PLoS ONE. 2019;14:e0221776.","journal-title":"PLoS ONE"},{"key":"9615_CR33","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1756-0500-5-452","volume":"5","author":"E Ermiah","year":"2012","unstructured":"Ermiah E, et al. Diagnosis delay in Libyan female breast cancer. BMC Res Notes. 2012;5:452.","journal-title":"BMC Res Notes"},{"key":"9615_CR34","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s11864-023-01138-4","volume":"24","author":"A Ismail","year":"2023","unstructured":"Ismail A, Choi S, Boussios S. Frontiers of Ovarian Carcinosarcoma. Curr Treat Options Oncol. 2023;24:1667\u201382.","journal-title":"Curr Treat Options Oncol"}],"container-title":["Journal of Mammary Gland Biology and Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10911-026-09615-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09615-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10911-026-09615-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:04:50Z","timestamp":1791821090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10911-026-09615-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9615"],"URL":"https:\/\/doi.org\/10.1007\/s10911-026-09615-w","relation":{},"ISSN":["1083-3021","1573-7039"],"issn-type":[{"value":"1083-3021","type":"print"},{"value":"1573-7039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23"}}